Disc Medicine, Inc.
NASDAQ:IRONBiotechnology
-$0.02 today
- Market cap
- $2.92B
- Beta
- 2.10
- P/E (TTM)
- -11.2
- EPS (TTM)
- -$6.28
Volume 0.65M
Average 0.47M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Disc Medicine, Inc.
NASDAQ:IRON
Intrinsic Alpha fair value
Locked
Current Price
$76.11
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A4 analysts |
| Revenue | N/A | N/A | N/A | N/A5 analysts |
| Net Income | N/A | N/A | N/A | N/A5 analysts |
| EBIT | N/A | N/A | N/A | N/A5 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Protagonist Therapeutics, Inc. NASDAQ:PTGX | $8.55B | $130.95 | Undervalued | -64.2 | +47.29% |
Hemab Therapeutics Holdings, Inc. Common Stock NASDAQ:COAG | $1.91B | $40.86 | Not rated | — | — |
Agios Pharmaceuticals, Inc. NASDAQ:AGIO | $1.89B | $31.59 | Not rated | -4.7 | +17.05% |
Damora Therapeutics, Inc. NASDAQ:DMRA | $1.34B | $21.60 | Not rated | -0.1 | +40.06% |
Geron Corporation NASDAQ:GERN | $622.98M | $0.97 | Not rated | -12.3 | -17.00% |
Continue the stock analysis
Jump to another research area for this company.